HealthQuill Kenvue
Overuse of antibiotics
Drugs Health Pharma

J&J’s consumer division Kenvue floats $41bn IPO

Johnson & Johnson consumer arm Kenvue floats biggest US IPO since 2021. Kenvue is valued at $41bn after being divisioned off from US.

Read More
X